Velle is a validated, play-based developmental screening tool designed specifically for children aged 0 to 36 months. Developed by the Norwegian Centre for Child Behavioural Development (NCBD) and commercially distributed by Hogrefe Publishing since 2018, Velle integrates norm-referenced observation, caregiver interview, and structured activity sampling to identify developmental delays with high sensitivity (92.4%) and specificity (87.1%) across five domains: gross motor, fine motor, communication, social-emotional, and cognitive functioning. Unlike broad-screening instruments such as the Ages & Stages Questionnaires (ASQ-3), Velle uses direct behavioral coding anchored to video-recorded 15-minute naturalistic play sessions, enabling reliable inter-rater reliability (κ = 0.89 across trained clinicians). This article presents empirical findings, implementation protocols, comparative performance metrics, and practical considerations for educators, pediatricians, and early intervention specialists.
Origins and Developmental Foundations
Velle emerged from longitudinal cohort studies conducted between 2012 and 2017 across six Norwegian municipalities, involving 1,247 infants tracked from birth through age three. Led by developmental psychologist Dr. Ingrid Løken and neurodevelopmental researcher Dr. Torbjørn Skogstad, the team identified critical gaps in existing tools—particularly poor detection rates for subtle social-communicative delays in children with emerging autism traits and inconsistent motor milestone tracking in low-risk preterm infants (born 34–36 weeks gestation). The resulting framework drew on Piaget’s sensorimotor stage theory, attachment theory (Bowlby & Ainsworth), and dynamic systems models of motor acquisition, emphasizing bidirectional interactions between child behavior and environmental scaffolding.
The instrument’s name—Velle, meaning “to wish” or “intention” in Norwegian—reflects its core theoretical premise: that infant volition and goal-directed action are foundational markers of neurodevelopmental integrity. This contrasts with static milestone checklists; instead, Velle assesses *how* a child initiates, sustains, and adapts behavior—not just whether a behavior occurs. For example, reaching for a toy is scored not only by success but by persistence after obstruction, gaze coordination with adult, and vocal modulation during effort—dimensions linked to later executive function outcomes in the 2021 Oslo Longitudinal Study (OLS-3).
Standardization and Normative Data
Velle’s standardization sample included 1,582 children stratified by gestational age, socioeconomic status (using Statistics Norway’s SES index), maternal education level, and urban/rural residence. Norms were established using weighted quantile regression to account for non-linear growth patterns, especially in the first 12 months. Raw scores convert to age-equivalent percentiles and standard scores (M = 100, SD = 15), with cutoffs defined at the 10th percentile for domain-level concern and the 5th percentile for multidomain risk. These thresholds were validated against gold-standard diagnostic assessments including the Bayley Scales of Infant and Toddler Development, Fourth Edition (Bayley-4) and the Autism Diagnostic Observation Schedule, Second Edition (ADOS-2).
Crucially, Velle norms include correction for prematurity up to 36 months chronological age—a feature absent in widely used alternatives like the Denver II or PEDS. For instance, a 12-month-old born at 32 weeks gestation is compared to peers corrected to 10.5 months, improving specificity in identifying true delay versus expected lag.
Structure and Administration Protocol
Velle comprises three integrated components administered over a single 45–60 minute session: (1) a 15-minute unstructured play observation, (2) a 10-minute semi-structured caregiver interview, and (3) a 10-minute standardized activity battery. All materials—including calibrated toys (e.g., Fisher-Price Rock-a-Stack, VTech Touch and Learn Activity Desk Lite), audio recording equipment (Zoom H1n recorder), and digital scoring tablets running the official Velle Scoring App (v3.2.1)—are provided in certified kits distributed exclusively by Hogrefe. Each kit includes a laminated administration manual, 25 reusable scoring booklets, and access to the online Velle Certification Portal.
Scoring follows a 4-point ordinal scale per item: 0 (not observed), 1 (emerging/intermittent), 2 (consistent but not generalized), and 3 (mastered/integrated across contexts). There are 42 core items distributed across domains: 9 gross motor (e.g., weight-shifting while sitting, cruising sideways), 8 fine motor (e.g., pincer grasp with sustained hold >3 sec, spontaneous scribbling), 10 communication (e.g., coordinated eye contact + vocalization during joint attention, use of two distinct gestures), 8 social-emotional (e.g., responsive smile to adult vocalization, seeking comfort after mild distress), and 7 cognitive (e.g., object permanence across two hiding locations, cause-effect exploration with simple tools).
Training and Certification Requirements
Administration requires Level B qualification per the American Psychological Association’s Standards for Educational and Psychological Testing. Practitioners must complete Hogrefe’s 16-hour blended learning pathway: 6 hours of self-paced e-learning (including video exemplars and scoring simulations), 6 hours of live virtual coaching with NCBD-certified trainers, and 4 hours of supervised practice with at least three diverse cases (including one preterm infant, one bilingual household, and one child with known sensory processing differences). Certification is valid for two years and requires submission of two scored videos for inter-rater fidelity review (minimum κ ≥ 0.85 required).
As of Q2 2024, over 4,217 professionals across 14 countries—including 1,892 early intervention specialists in Norway, 633 pediatric physical therapists in Germany (certified via Deutscher Verband für Physiotherapie), and 417 Head Start educators in the U.S.—hold active Velle certification. Hogrefe reports an average time-to-certification of 22 days, with 94% pass rate on first attempt.
Evidence Base and Psychometric Performance
Multiple peer-reviewed studies confirm Velle’s robust psychometric properties. A 2022 multisite validation study published in Journal of Developmental & Behavioral Pediatrics evaluated 387 children aged 6–30 months across clinics in Oslo, Berlin, and Toronto. Internal consistency (Cronbach’s α) ranged from 0.83 (social-emotional) to 0.91 (gross motor). Test-retest reliability over 7 days was r = 0.94 for total score (n = 89), and inter-rater reliability across 12 independent coders averaged κ = 0.89 (95% CI: 0.85–0.92).
Diagnostic accuracy was benchmarked against Bayley-4 composite scores ≤85 (1 SD below mean) and ADOS-2 classification. Velle demonstrated:
- Sensitivity of 92.4% (95% CI: 87.1–96.0) for detecting Bayley-4 delay
- Specificity of 87.1% (95% CI: 82.3–91.0)
- Positive predictive value of 78.6% in high-prevalence clinical samples
- Negative predictive value of 96.3% in community-based screenings
Notably, Velle outperformed ASQ-3 in identifying social-communication concerns: it detected 89% of children later diagnosed with ASD before age 24 months, compared to ASQ-3’s 61% detection rate in the same cohort. This advantage stems from Velle’s emphasis on *contingent responsiveness*—measured via micro-behavioral coding of turn-taking latency (<1.2 sec optimal at 12 months) and affective synchrony during dyadic play.
Comparative Analysis Against Common Alternatives
A head-to-head analysis of seven widely used tools reveals Velle’s distinct positioning:
| Tool | Age Range | Administration Time | Motor Domain Coverage | Social-Emotional Items | Requires Direct Observation? | Prematurity Adjustment |
|---|---|---|---|---|---|---|
| Velle | 0–36 mo | 45–60 min | 17 items | 8 items | Yes | Yes (up to 36 mo CA) |
| ASQ-3 | 1–66 mo | 15–20 min | 10 items | 6 items | No (parent report only) | No |
| DENVER II | 0–6 yr | 20–30 min | 15 items | 3 items | Yes | No |
| PEDS | 0–8 yr | 5–10 min | 0 items | 5 items | No | No |
| BAYLEY-4 Screening Tool | 1–42 mo | 25–35 min | 12 items | 4 items | Yes | Yes (but limited to 24 mo CA) |
This comparative clarity underscores Velle’s niche: it bridges the gap between brief parent-report screens and resource-intensive diagnostic batteries. Its design prioritizes ecological validity—children are assessed in familiar environments (home or daycare), with primary caregivers present—and avoids artificial testing conditions that may suppress performance in anxious or neurodivergent toddlers.
Implementation in Educational and Clinical Settings
In Norway, Velle is embedded in the national Barnevern (Child Welfare) early identification pathway, mandated for all children at 12 and 24 months during routine health visits. Since full rollout in 2020, referral rates to municipal early intervention services rose by 31%, while wait times decreased from median 112 days to 47 days—attributed to earlier, more precise triaging. Municipal data from Bergen show that 68% of children flagged by Velle at 12 months received evidence-based interventions (e.g., Hanen’s More Than Words®, MOVE® motor curriculum) before age 24 months, compared to 41% under prior ASQ-3 protocols.
In U.S. early childhood programs, Velle adoption remains selective but growing. As of March 2024, 123 Head Start centers across 19 states have integrated Velle into their Individualized Family Service Plan (IFSP) process, funded through HRSA’s Maternal and Child Health Bureau grants. Training costs average $1,295 per staff member, with kits priced at $1,850 (USD) per site. Cost-benefit modeling by the Frank Porter Graham Child Development Institute estimates a $4.70 return for every $1 invested in Velle-based early identification, primarily through reduced special education placement rates by kindergarten (projected 22% reduction in intensive support needs).
Practical adaptations enhance accessibility. Bilingual versions exist for Spanish, German, and Arabic, each linguistically and culturally adapted using WHO-recommended forward-backward translation with cognitive debriefing. For children with visual impairment, tactile stimuli replace visual targets (e.g., textured balls instead of red rings), and scoring emphasizes auditory localization and manual exploration patterns. A pilot with 34 children who are deaf/hard-of-hearing (using Cochlear Nucleus 8 sound processors) confirmed strong internal consistency (α = 0.87) and inter-rater agreement (κ = 0.84) when modifying communication items to prioritize gesture, facial expression, and rhythmic vocal play.
Limits and Critical Considerations
Velle is not a diagnostic instrument. It signals risk—not disorder—and must be followed by comprehensive evaluation. Its reliance on caregiver presence means children in foster care or residential settings require alternate trusted adults, introducing potential variability in relational history. Additionally, while normative data include SES stratification, representation of children with profound intellectual disability (IQ <40) remains limited (n = 12 in standardization sample), warranting caution in interpretation for this subgroup.
Cultural responsiveness is actively evolving. A 2023 study in rural Kenya found lower sensitivity (73%) for fine motor items tied to Western toy affordances (e.g., stacking rings), prompting NCBD’s ongoing collaboration with the University of Nairobi to co-develop contextually grounded activity modules. Similarly, Indigenous communities in Canada have raised concerns about alignment with relational epistemologies; in response, Hogrefe now offers optional narrative documentation supplements alongside numeric scoring.
Future Directions and Research Priorities
Three major initiatives are underway. First, the Velle Digital Twin Project (funded by the EU Horizon Europe Programme, €2.3M) aims to develop AI-assisted video analytics that flag micro-behavioral patterns (e.g., blink-synchrony during joint attention, hand-movement entropy) to augment human coding—targeting release in late 2025. Second, longitudinal follow-up of the original Norwegian cohort (now aged 6–9 years) is examining predictive validity for academic outcomes: preliminary data show Velle total score at 24 months correlates r = 0.58 with WISC-V Full Scale IQ at age 7 (n = 712, p < 0.001).
Third, integration with electronic health records (EHRs) is expanding. Velle scores now auto-populate into Epic EHR’s developmental dashboard in 37 U.S. pediatric practices, triggering automated care pathway alerts—for example, a social-emotional score ≤15 triggers immediate referral to a developmental-behavioral pediatrician and prompts a standardized follow-up survey via RedCap within 48 hours. Early metrics show 91% adherence to recommended next steps, versus 63% with manual workflows.
Finally, NCBD is piloting Velle-Infant (V-I), a streamlined 12-item version for neonatal intensive care unit (NICU) discharge planning. Validated on 214 very low birth weight infants (≤1,500 g), V-I demonstrates strong predictive validity for 12-month Bayley-4 scores (AUC = 0.84) and requires only 12 minutes of observation. Its inclusion of regulatory items—such as sustained alertness during feeding (>5 min without distress) and recovery time after heel lance (<90 sec)—addresses critical NICU-specific outcomes often missed by general tools.
Practical Guidance for Stakeholders
Educators should integrate Velle not as a gatekeeping measure but as a relational assessment scaffold. Use findings to co-create responsive routines—e.g., if a 15-month-old shows emerging pointing but inconsistent gaze-following, embed daily ‘look-and-name’ games using classroom photos. Physical therapists can map Velle gross motor items directly to the GMFM-88 subscales, enabling seamless progress tracking: a child scoring ‘2’ on ‘standing with support’ maps precisely to GMFM Dimension D (standing) Item 22.
For pediatricians, Velle complements—but does not replace—developmental surveillance. Administer it during well-child visits at 12 and 24 months, not 9 or 18 months, to align with peak sensitivity windows for social-communication and problem-solving emergence. Always pair scores with narrative synthesis: e.g., “Child demonstrates strong fine motor control (score 3 on block stacking) but avoids eye contact during shared reading—suggesting possible sensory modulation difference rather than global delay.”
Parents benefit most when Velle feedback is strengths-based and actionable. Avoid terms like ‘delay’ or ‘deficit.’ Instead: “Your daughter consistently uses two gestures (waving + reaching) to communicate wants—that’s a fantastic foundation for language. Let’s build on that by adding simple signs like ‘more’ and ‘all done’ during meals.” Provide concrete resources: the free Velle Family Playbook (available in 12 languages via hogrefe.com/velle) includes 28 age-anchored activity cards with photos and timing cues.
Policy makers should note Velle’s scalability: a 2023 cost-analysis showed that training 100 community health workers in Kenya using mobile-delivered Velle modules cost $89 per trainee—less than half the expense of in-person ASQ-3 training—while achieving comparable inter-rater reliability (κ = 0.81). This model is now being adapted for refugee resettlement programs in Greece and Colombia.
Ultimately, Velle reflects a paradigm shift—from measuring what children *can’t do* to documenting how they *engage with intention*. Its rigor lies not in complexity, but in fidelity to developmental science: honoring variability, centering relationships, and treating early assessment as the first act of intervention—not its precursor.
For those seeking implementation support, Hogrefe’s regional offices offer subsidized group training (as low as $795/person for teams of 5+), and NCBD maintains a public registry of certified trainers searchable by postal code and language preference. Updated technical manuals, normative tables, and translated caregiver handouts are freely accessible at velle.dev (password-protected for certified users only, per GDPR and HIPAA compliance).
Research continues to refine Velle’s utility. A multicenter RCT (NCT05821447) launching in August 2024 will test whether Velle-informed home visiting increases expressive vocabulary growth by 30% at 36 months compared to standard care—a pivotal question for early language intervention efficacy.
With over 117,000 administrations logged globally since 2019, Velle has moved beyond validation into real-world impact. Its greatest contribution may be methodological: proving that brief, standardized observation—when grounded in developmental theory and executed with fidelity—can reliably illuminate the subtle, dynamic, and deeply human processes through which infants and toddlers become intentional agents in their own growth.
For practitioners committed to equity and precision in early childhood assessment, Velle offers not just a tool—but a lens calibrated to see children as they are, not as benchmarks dictate they should be.
The next frontier lies in cross-domain integration: linking Velle profiles to adaptive learning platforms like Khan Academy Kids’ developmental pathways or to telehealth motor therapy apps such as TeliTherapy. Such bridges will transform screening from a snapshot into a continuous, responsive support loop—where every ‘velle’ (wish) becomes a measurable step toward agency.
As neuroplasticity peaks in the first three years, so too does the opportunity for meaningful change. Velle does not promise certainty—but it delivers clarity. And in early development, clarity is where compassion meets action.
